Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 307.66
- Piotroski Score 4.00
- Grade N/A
- Symbol (CDT)
- Company Conduit Pharmaceuticals Inc.
- Price $0.10
- Changes Percentage (3.68%)
- Change -$0
- Day Low $0.10
- Day High $0.11
- Year High $7.83
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/18/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.03
- Trailing P/E Ratio -94.67
- Forward P/E Ratio -94.67
- P/E Growth -94.67
- Net Income $-535,000
Income Statement
Quarterly
Annual
Latest News of CDT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Conduit Pharmaceuticals Inc. (CDT) Stock Price, News, Quote & History - Yahoo Finance
Conduit Pharmaceuticals Inc. is a biopharmaceutical company focusing on autoimmune diseases and male infertility. It has developed potential treatments like AZD1656 for various conditions and AZD5904 ...
By Yahoo! Finance | 2 months ago
